Epha3 contributes to epigenetic suppression of pten in ra-dioresistant head and neck cancer

17Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

EPHA3, a member of the EPH family, is overexpressed in various cancers. We demon-strated previously that EPHA3 is associated with radiation resistance in head and neck cancer via the PTEN/Akt/EMT pathway; the inhibition of EPHA3 significantly enhances the efficacy of radiotherapy in vitro and in vivo. In this study, we investigated the mechanisms of PTEN regulation through EPHA3-related signaling. Increased DNA methyltransferase 1 (DNMT1) and enhancer of zeste homolog 2 (EZH2) levels, along with increased histone H3 lysine 27 trimethylation (H3K27me3) levels, correlated with decreased levels of PTEN in radioresistant head and neck cancer cells. Furthermore, PTEN is regulated in two ways: DNMT1-mediated DNA methylation, and EZH2-mediated histone methylation through EPHA3/C-myc signaling. Our results suggest that EPHA3 could display a novel regulatory mechanism for the epigenetic regulation of PTEN in radi-oresistant head and neck cancer cells.

Cite

CITATION STYLE

APA

Kim, S. H., Kang, B. C., Seong, D., Lee, W. H., An, J. H., Je, H. U., … Han, M. W. (2021). Epha3 contributes to epigenetic suppression of pten in ra-dioresistant head and neck cancer. Biomolecules, 11(4). https://doi.org/10.3390/biom11040599

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free